Page URL:

Embryonic stem cells self-destruct for the greater good

8 May 2012
Appeared in BioNews 655

Human embryonic stem cells (hESCs) are primed to self destruct in response to DNA damage in the developing embryo, scientists have reported. The research found that hESCs are highly responsive to DNA damage in the early stages of development, and can commit suicide for the greater good.

Embryonic stem cells give rise to every type of cell in the body and so it is vital that there are controls to stop any DNA damage being passed on throughout the embryo.

Dr Mohanish Deshmukh, who led the study at the University of North Carolina, said: 'Mutations that develop in these cells could be catastrophic for the developing organism, so it would make sense for these cells to be rapidly eliminated'.

The researchers used a chemotherapy drug to induce DNA damage in hESCs and found that almost all the cells died within five hours of exposure. This is much faster than fully matured cells, such as fibroblasts, which take 24 hours.

The hESCs were more resilient to other types of cellular stress that did not damage the DNA, suggesting they have a particular sensitivity to DNA damage.

The study, published in Molecular Cell, focused on the basic cell biology behind this sensitivity to DNA damage. Normally, a protein called Bax is switched on in cells undergoing this programmed cell death, which then directs the cell to die. However, they found that in hESCs it is switched on all the time, something previously unheard of.

'I was stunned', said Dr Deshmukh. 'I thought something was wrong. We spent a lot of time convincing ourselves that these cells were healthy and not actively dying'.

He explained that these cells do something 'very clever' - they keep Bax locked in a compartment of the cell called the Golgi, where it cannot switch the death process on. This means that if the DNA is damaged the cell can respond much more rapidly by releasing Bax from the Golgi.

This sensitive state appears to last only a few days during early development, as even 24 hours after the hESCs begin to differentiate into other cell types Bax is no longer switched on.

Dr Christopher Navara who studies embryonic stem cells at the University of Texas at San Antonio and was not involved in the study, described the research as 'convincing' in an email to The Scientist.

Human Embryonic Stem Cells Have Constitutively Active Bax at the Golgi and Are Primed to Undergo Rapid Apoptosis
Molecular Cell |  3 May 2012
Stem cells poised to self-destruct for the good of the embryo
EurekAlert! |  3 May 2012
Stem Cell Suicide Switch
The Scientist |  3 May 2012
31 January 2012 - by Dr Dusko Ilic 
In the last few months of 2011, a couple of stories on human embryonic stem cells hit the headlines. Both were bad news for stem cell researchers...
19 December 2011 - by Antony Starza-Allen 
A survey of over 200 human embryonic stem cell (hESC) researchers in the US has found almost four in ten respondents had experienced delays in obtaining cell lines and over one-quarter said they were unable to obtain a required cell line at all....
21 November 2011 - by Rosemary Paxman 
A US drug company is abandoning its research into a novel paralysis treatment using embryonic stem cells, due to current economic conditions....
14 November 2011 - by Luciana Strait 
Human embryonic stem cells have been used to treat a model of Parkinson's disease, rats and monkeys, pointing to a possible new way of treating the condition....
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.